National Academies Press: OpenBook

Financing Vaccines in the 21st Century: Assuring Access and Availability (2004)

Chapter: Appendix D: Overview of Commissioned Papers

« Previous: Appendix C: Survey of State Vaccine Finace Practices
Suggested Citation:"Appendix D: Overview of Commissioned Papers." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page 241
Suggested Citation:"Appendix D: Overview of Commissioned Papers." Institute of Medicine. 2004. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press. doi: 10.17226/10782.
×
Page 242

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix D Overview of Commissioned Papers The IOM committee commissioned eight background papers as part of the collection of evidence to support this study. The commissioned pa- pers are briefly described below. 1. Trends In Vaccine Prices, 1992-2002. Provides a quantitative analy- sis of vaccine trends using two different data sources, and analyzes the impact of market structure variables on these trends. Frank Lichtenberg, Graduate School of Business, Columbia Univer- sity 2. An Overview of the Market for Vaccines in the United States. Presents a comprehensive industrial organization analysis of the market for vaccines in the United States, with a focus on production and licensing processes and the mixed public-private market for vaccines. Richard Arnould and Larry DeBrock, Department of Economics, University of Illinois at Urbana-Champaign 3. How Insurance Companies and Health Plans Are Planningfor New Vac- cines. Through interviews with health plans and state officials, considers how private and public insurance plans make decisions about insurance benefits for vaccine products and provider fees, with a focus on future strategies in light of rising vaccine costs. Kathy Swartz, School of Public Health, Harvard University 241

242 FINANCING VACCINES IN THE 21ST CENTURY 4. Vaccine Purchase and Distribution: Proposed Changes in Vaccine Supply and Delivery Policies. Based on a series of interviews with key policy mak- ers, reviews proposals made by industry, government, medical profes- sional organizations, and other stakeholders to fix the current system through a wide range of proposed reforms. Gerry Fairbrother and Arfana Haidery, New York Academy of Medi- cine 5. Setting Prices for New Vaccines (in Advance). Presents an economic model for calculating a price for future vaccines in advance as a way to stimulate investment in vaccine development and determine an accept- able price in the absence of a functioning market. Thomas McGuire, Department of Health Care Policy, Harvard Medi- cal School 6. Vaccine Policy Perspectives: Market Strategies. Considers a wide array of strategic options for improving the financing of vaccines through mar- ket-based approaches such as price incentives, a voucher system to dis- tribute vaccines, and reduced barriers to global competition in the United States. Joel Hay and Danielle Zammit, Department of Economics, University of Southern California 7. Estimating the Need for Publicly Purchased Vaccine for Adults and Chil- dren. Provides estimates of the numbers and characteristics of child and adult populations that require assistance in purchasing vaccines and a description of how such assistance is currently received through state and federal public health and private health care systems. David Wood, Delmarva Foundation 8. Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP): A Case Study. Presents a case study analysis of the DTaP vaccine illustrating the changes in the vaccine market over time; based on structured interviews with regulators, industry executives, and providers. Amy Fine, Consultant, Washington, DC

Next: Appendix E: Commitee and Staff Biographies »
Financing Vaccines in the 21st Century: Assuring Access and Availability Get This Book
×
Buy Paperback | $37.00 Buy Ebook | $29.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The national immunization system has achieved high levels of immunization, particularly for children. However, this system faces difficult challenges for the future. Significant disparities remain in assuring access to recommended vaccines across geographic and demographic populations. These disparities result, in part, from fragmented public–private financing in which a large number of children and adults face limited access to immunization services. Access for adults lags well behind that of children, and rates of immunizations for those who are especially vulnerable because of chronic health conditions such as diabetes or heart and lung disease, remain low.

Financing Vaccines in the 21st Century: Assuring Access and Availability addresses these challenges by proposing new strategies for assuring access to vaccines and sustaining the supply of current and future vaccines. The book recommends changes to the Advisory Committee on Immunization Practices (ACIP)-the entity that currently recommends vaccines-and calls for a series of public meetings, a post-implementation evaluation study, and development of a research agenda to facilitate implementation of the plan.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!